GI Oncology
Latest News
Should race and ethnicity be used in CRC recurrence risk algorithms?
Removing race from clinical risk predictions could lead to higher racial bias in model accuracy and less accurate estimation of risk in some...
Conference Coverage
Unprecedented drop seen in early colorectal cancer cases due to aspirin use
The study confirms evidence from 30 years of research that suggests regular aspirin use reduces cancer risk.
From the Journals
How BMI over time impacts GI cancer risk
These “important findings highlight the unmet need to identify the critical time window linking adiposity and GI cancer.”
From the Journals
New AI tool may help predict best treatments for colorectal cancer
The tool is not yet ready for clinical use. When it is, the tool has the potential to provide timely, accurate decision support based on tumor...
Conference Coverage
CRC screening rates are higher in Medicaid expansion states
Medicaid expansion may be a determinant of whether screening is even offered.
Conference Coverage
Liver transplants for CRC metastases: Coming into its own?
Transplantation is emerging as an attractive option for select patients with nonresectable CRC liver metastases, and patients with intrahepatic...
Conference Coverage
African ancestry genetically linked to worse CRC outcomes
Results from a new study provide greater clarity regarding the genetic piece of the puzzle.
News
Refined incidence rate of HCC with alcohol-associated cirrhosis encourages surveillance
Cumulative risk of HCC in patients with alcohol-associated cirrhosis was 3% after 5 years, and 9% after 10 years.
Feature
CRC blood tests: A future without screening colonoscopies?
Screening colonoscopies ultimately could be largely phased out in the years ahead in favor of highly sensitive noninvasive tests, if the blood...
From the Journals
Gene variants plus H. pylori increase risk of gastric cancer
The new findings imply that the hereditary contribution to the risk of gastric cancer is more important than previously believed.
News
Review explores the boundaries of endoscopic resection for esophageal adenocarcinoma
Technical advances are expanding the population of patients who are candidates for endoscopic resection of esophageal adenocarcinoma.